Member Info for DSFLAT

Stalicla deal gets sorted and all is good ;-)

The BCH map of retail that accept Bitcoin Cash as payment may be a better example of how Crypto or in this case Bitcoin Cash has value even in its infancy:

https://map.bitcoin.com/

I would add that BTC with small blocks isn't and cannot be A P2P Electronic Cash System for the world which was the whole point of Satoshi creating Bitcoin in the first place

Bitcoin Cash: A Peer-to-Peer Electronic Cash System

The same 21M max supply as BTC

Same halvings

Same miners

Same Genesis block

BCH big blocks, scales on-chain, is fast and cheap to transact P2P on L1

Bitcoin Cash is up over 300% in one year, around twice as much as BTC and the BCH chart looks like Bitcoin in 2016

FG said QBT were setting up a mining operation about 2 years ago, he could have bought a few rigs and mined BCH as a solo miner (solo miners still finding blocks)...

Investors could have seen results by way of BCH HODL and FG could have built a stronger narrative around QBT's R&D...

Just saying

Fleccy, it is already possible to buy Amazon products using Bitcoin Cash on Bitgree so maybe time to give up on the Bitcoin has no real value or real world use ;-)

https://www.bitgree.com/buy-things

"The company has also conducted an interventional phase 1b study establishing good safety and tolerability, strong dose-related target engagement and strong correlation between dosage and improvement of autism severity standardized scores (ABC, SRS) with a manuscript currently under review."

Presumably we wait for the review and then we know one way or the other, Stalicla do seem to be pushing forward on several fronts so perhaps it's simply a case of prioritization...

My guess is that Stalicla wanted to tie up SFX-01 (medical grade Sulforaphane) but test using a non synthetic Sulforaphane to establish a benchmark.

By entering into the agreement with Evgen they could presumably then look into using other readily available forms of Sulforaphane and compare results, cost analysis and future product protection i.e Patent longevity with SFX-01 or alternative solutions.

Perhaps even considering a production of their own Sulforaphane product ?

Theracryf not reporting on the recent Stalicla test results isn't encouraging for me and might suggest SFX-01 hasn't been used in testing at all.

Are Stalicla waiting for better patient diagnostics as mentioned in their paper ? With the WaveDancer, Firefly Neuroscience merger playing a part in their commercialization strategy ?

We've got a new name, new products, we just need a new CEO ;-)

'The compound is unstable in solutions, freshly prepared is recommended.'

https://www.medchemexpress.com/Sulforaphane.html

Presumably Stalicla are replicating the tests using SFX-01 to compare data...

"Overall, our results support the use of integrative systems biology toward the characterization of mechanistically defined and clinically actionable subgroups in ASD and the corresponding tailored treatments. Lastly, this approach paves the way for precision medicine-based drug discovery in NDDs."

Looking at the publication it looks like Sulforaphane was a success ( I'm not a medical expert ;) but the Sulforaphane used wasn't SFX-01 ?

STALICLA publishes on identification of first autism subgroup and matching treatment

Geneva, Switzerland, May 8, 2024 – STALICLA SA, a Swiss neuro precision biotech company, has provided proof-of-concept clinical data for DEPI (Databased Endophenotyping Patient Identification), its neuro precision discovery platform, enabling the identification of biological subgroups of patients with Autism Spectrum Disorder (ASD) and matching treatments, in a study published last week in Biomedicines

https://stalicla.com/media/news/stalicla-publishes-on-first-precision-medicine-study

Https://www.mdpi.com/2227-9059/12/5/991

Https://www.mdpi.com/2227-9059/12/5/991

STALICLA publishes on identification of first autism subgroup and matching treatment

Geneva, Switzerland, May 8, 2024 – STALICLA SA, a Swiss neuro precision biotech company, has provided proof-of-concept clinical data for DEPI (Databased Endophenotyping Patient Identification), its neuro precision discovery platform, enabling the identification of biological subgroups of patients with Autism Spectrum Disorder (ASD) and matching treatments, in a study published last week in Biomedicines

https://stalicla.com/media/news/stalicla-publishes-on-first-precision-medicine-study

Are we seeing a slow bleed from BTC into BCH ?

BCH is up about 300% in one year, over twice as much as BTC..

BTC with small blocks isn't and cannot be a P2P Electronic Cash System for the world which was the whole point of Satoshi creating Bitcoin in the first place

Bitcoin Cash: A Peer-to-Peer Electronic Cash System

The same 21M max supply as BTC

Same halvings

Same miners

Same Genesis block

BCH big blocks, scales on-chain, is fast and cheap to transact P2P on L1

Just saying ;-)

NChain have patents granted in the US and the UK for POW mining.

I'm guessing nChain could send out cease and desist letters to miners....

CSW would likely send one to Iren as a poke in the eye at Peter McCormack but I'm not sure CSW has much of a role at nChain.

Presumably nChain could send out Cease and desist letters in the future, settle for royalty payments or go to court...

Date of Patent 7th May 2024

Systems and Methods for mining on a POW Network

https://ppubs.uspto.gov/dirsearch-public/print/downloadPdf/11979499

Interesting...

I would add that sitting on some heavy paper losses It's not all Rainbows and Unicorns for me and I hope Stalicla or some other news gets me out of a flipping big hole.

Too late for me to repent

Come on Huw do something to get this festering turd going in the right direction ffs

With respect BJ39 if Stalicla hadn't flucked around your post would be as pointless as it is condescending ;-)

Should be good for business all those blood clots

OH SH*T, AstraZeneca Just ADMITTED Vax Causes Blood Clots!

Russell Brand

150K views 15 hours ago

https://youtu.be/PcLrAs3C5B8?si=FwQ7cg036oSDf9QQ

We just need one of the big fish in the Pharma world to take a second look at Theracryf and Stalicla

https://www.stalicla.com/media/events

Presumably Stalicla were exhibiting this week at LSX..

https://informaconnect.com/lsx-world-congress/

aim company with a £12m mcap, no rev, little cash and a proven bull****ter ceo...

i'd say the shorts are going to make bank

but wtf do i know